Skip to main content
OpenTrials

Clinical trial condition

Ependymoma

Explore clinical trials studying Ependymoma. Study availability and eligibility vary by location and protocol.

170 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Ependymoma trial results

Completed

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

NCT03213678

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +82 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 127 locations
View Trial Details
Completed

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

NCT03213665

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 117 locations
View Trial Details
Completed

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

NCT03526250

Conditions
Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +81 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 117 locations
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

NCT04238819

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) Los Angeles, California, United States
  • Kaiser Permanente Oakland Oakland, California, United States
  • Kaiser Permanente Roseville Roseville, California, United States
View all 25 locations
View Trial Details
Completed

Molecular-Guided Therapy for Childhood Cancer

NCT02162732

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +65 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View all 19 locations
View Trial Details
Completed

HUMC 1612: Optune NovoTTF-200A System

NCT03128047

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
  • Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions